Shared decision making on active surveillance versus immediate surgery in patients with esophageal cancer.
- Conditions
- Esophageal cancer
- Registration Number
- NL-OMON27295
- Lead Sponsor
- Erasmus MC - University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
-Patients who are planned to undergo neoadjuvant chemoradiotherapy according to CROSS, followed by either surgical resection for histologically proven and resectable esophageal squamous cell carcinoma or adenocarcinoma of the esophagus or esophago-gastric junction, without distant dissemination or by active surveillance.
Exclusion Criteria
A potential subject who meets any of the following criteria will be excluded from
participation in this study:
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main study parameter is increased knowledge and understanding of the factors relevant for treatment decision making in esophageal cancer patients. Based on the analyses of the interview data, we will develop a model/theory on the factors that influence treatment decision in esophageal cancer patients. This theory, combined with results of the quantative part of this study, will determine the design of the decision aid. This decision aid is a tangible main outcome/endpoint of this study and meant for future use in clinical practice
- Secondary Outcome Measures
Name Time Method Secondary study parameters include data on the relationship between treatment decision on the one hand and on the other hand health literacy, anxiety, coping, quality of life and decisional regret.